Applied Therapeutics Company Insiders

Applied Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.8835) % which means that it has lost $0.8835 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.8047) %, meaning that it created substantial loss on money invested by shareholders. Applied Therapeutics' management efficiency ratios could be used to measure how well Applied Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.47 in 2026. Return On Capital Employed is likely to drop to -2.12 in 2026. Change To Liabilities is likely to gain to about 10.7 M in 2026, whereas Total Current Liabilities is likely to drop slightly above 27.4 M in 2026. Common Stock Shares Outstanding is likely to gain to about 168.5 M in 2026, despite the fact that Net Loss is likely to grow to (90.3 M). Applied Therapeutics holds a total of 144.3 Million outstanding shares. Over half of Applied Therapeutics' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. At this time, Applied Therapeutics' Days Of Payables Outstanding is comparatively stable compared to the past year. Long Term Debt To Capitalization is likely to gain to 0.1 in 2026, whereas Operating Cash Flow Per Share is likely to drop (0.57) in 2026.

Applied Therapeutics Workforce Comparison

Applied Therapeutics Insider Trading

Applied Therapeutics Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Applied Therapeutics often depends on how effective the management is. Applied Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Applied management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Applied management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Applied Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Applied Therapeutics. Check Applied Therapeutics' Beneish M Score to see the likelihood of Applied Therapeutics' management manipulating its earnings.

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.